Kenya vs Zimbabwe: HIV/AIDS deaths averted by antiretroviral therapy
Kenya
75,293 deaths
in 2024
Zimbabwe
84,960 deaths
in 2024
Kenya rank
8th
Zimbabwe rank
5th
HIV/AIDS deaths averted by antiretroviral therapy over time
- Kenya
- Zimbabwe
How they compare
Zimbabwe currently reports 84,960 deaths against 75,293 deaths in Kenya, a difference of 9,667 deaths.
That makes Zimbabwe's figure about 1.1 times Kenya's.
The two have swapped places 4 times across 35 shared years of data; in 1990 it was Zimbabwe ahead.
Kenya ranks 8th and Zimbabwe ranks 5th of 157 countries.
Across the 4 decades both report, Kenya averaged higher in 1 and Zimbabwe in 3.
Head to head by decade
| Decade | Kenya | Zimbabwe | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 275.56 deaths | 275.56 deaths | Zimbabwe |
| 2000s | 18,197 deaths | 11,375 deaths | 6,822 deaths | Kenya |
| 2010s | 71,552 deaths | 75,537 deaths | 3,985 deaths | Zimbabwe |
| 2020s | 75,330 deaths | 86,746 deaths | 11,416 deaths | Zimbabwe |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Kenya or Zimbabwe?
- Zimbabwe, at 84,960 deaths against 75,293 deaths in Kenya as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Kenya and Zimbabwe?
- 9,667 deaths, with Zimbabwe ahead.
- How many years of comparable data are there for Kenya and Zimbabwe?
- 35 years are reported by both, from 1990 to 2024.
- How do Kenya and Zimbabwe rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Kenya ranks 8th and Zimbabwe ranks 5th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.